BHEKISISA: Lenacapavir offers extraordinary promise but communication will decide its impact
A groundbreaking HIV prevention injection will only achieve its full impact if scientific advances are matched by clear, accessible communication that reaches the communities they are designed to…
Read the full articleYou might also wanna read
FDA Approves First 100% Effective HIV Prevention Drug with Global Impact
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug that offers 100%

Lenacapavir and the shift to NRTI-free, long-acting HIV treatment: implications for HBV patients
An exciting shift is underway in progress towards tackling HIV as a global public health threat, as we enter a new era of nucleotide and nuc
Proposed NIH Budget Cuts Threaten HIV Breakthroughs Like Lenacapavir, Article Argues
Biomedical advances such as lenacapavir depend on years of publicly funded basic research
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Conditions : HIV-1-infection Interventions : Drug: Lenacapavir; Drug: Lenacapavir Tablet; Drug: Teropavimab; Drug: Zinlirvimab; Drug: SBR Sp
New injection medication among various options to treat HIV infection
Interview with Upstate's Elizabeth Asiago-Reddy, MD, who specializes in the care and treatment of people with HIV/AIDS

Protecting Science. Advancing HIV Prevention. Preparing for What’s Next
Global health is being reshaped by rapid geopolitical shifts, scientific breakthroughs and the growing role of artificial intelligence — cre

Comments
Sign in to join the conversation.
No comments yet. Be the first.